Expert Biography

Dr. Robert J. Mackenzie's picture

Dr. Robert J. Mackenzie

Current: Dr. Robert J. MacKenzie is a family therapist, educational psychologist, and nationally recognized parent educator and staff development trainer with more than 25 years of experience helping parents and teachers solve children’s learning and behavior problems. In addition to providing family counseling and parent/teacher training workshops, Dr. MacKenzie writes for magazines and educational journals and consults privately with schools, hospitals, parent/teacher organizations, colleges, church groups and wide variety of community service agencies. Dr. MacKenzie is a member of the American Psychological Association and the author of three books: Setting Limits helps parents teach rules and establish clear, firm boundaries for children of all ages and temperaments; Setting Limits in the Classroom is a skill-training program for teachers in effective classroom management; and Setting Limits with Your Strong-Willed Child helps parents and teachers teach rules and gain cooperation from challenging, hard-to-raise children who engage us in more testing and power-struggles.

Website: settinglimits.com

Contributions by Dr. Robert J. Mackenzie:

Videos:
  • Time Out: More Harm Than Good?

    The "D" word. Discipline. One of the most challenging aspects of parenting. Deciding on how, when and why to discipline can cause not only anxiety in ourselves, but friction between parents. And worse, if done improperly it could cause resentment and further aggression from a child. So how do you decide on which method to use and how do you know if it causes more harm than good? Our Parents Ask experts share their thoughts on one of the most popular and debated methods: Time Out.

Have a Question?

Ask the experts at ParentsAsk.com

How it Works

Quick Poll

Do you think today's kids are over-medicated?

Yes! It seems like there's a pill for everything with little concern for the side effects.
16%
No. I think more kids are being helped by the availability of new medicines.
84%